Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


Consciousness and Psilocybin Effects on Well-Being (The CoPE Study): Pilot Phase


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05592379

Organisation Name: University of Wisconsin, Madison

Overal Status: Not yet recruiting

Start Date: March 2023

Last Update: November 8, 2022

Lead Sponsor: University of Wisconsin, Madison

Brief Summary: This pilot study aims to 1) establish a dosing regimen for intravenous (IV) psilocybin that will allow the drug to be administered to asleep participants without awakening them; and 2) assess whether this dosing regimen produces a psychedelic experience.

Conditions:
  • Healthy
  • Psychedelic Experiences
  • Sleep


Total execution time in seconds: 0.18373203277588